Copaiba oil suppresses inflammatory cytokines in splenocytes of C57Bl/6 mice induced with experimental autoimmune encephalomyelitis (EAE)

Molecules

Volumn 19, Issue 8, 2014, Pages 12814-12826

  Dias, Débora S ^a   Fontes, Lívia B A ^a   Crotti, Antônio E M ^b   Aarestrup, Beatriz J V ^a   Aarestrup, Fernando M ^a   Da Silva Filho, Ademar A ^a   Corrêa, José O A ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Copaiba oil; Experimental autoimmune encephalomyelitis; Immunomodulatory; Multiple sclerosis; Natural products

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; HYDROGEN PEROXIDE; NITRIC OXIDE; VEGETABLE OIL;

ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; DRUG SCREENING; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FABACEAE; FEMALE; IMMUNOLOGY; METABOLISM; PATHOLOGY; SPLEEN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CYTOKINES; DRUG EVALUATION, PRECLINICAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FABACEAE; FEMALE; HYDROGEN PEROXIDE; MICE, INBRED C57BL; NITRIC OXIDE; PLANT OILS; SPLEEN;

EID: 84906707599     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190812814     Document Type: Article

References (34)

1. Zorzella-Pezavento, S.F.G.; Chiuso-Minicucci, F.; Ishikawa, L.L.W.; da Rosa, L.C.; Marques, C.; Ikoma, M.R.V.; Sartori, A. Persistent inflammation in the CNS during chronic EAE despite local absence of Il-17 production. Mediat. Inflamm. 2013, 2013, doi:10.1155/2013/519627.
2. Gasperini, C.; Ruggieri, S.; Mancinelli, C.R.; Pozzilli, C. Advances in the treatment of relapsing-remitting multiple sclerosis - Critical appraisal of Fingolimod. Ther. Clin. Risk Manag. 2013, 9, 73-85.
3. Corrêa, J.O.D.A.; Aarestrup, B.J.V.; Aarestrup, F.M. Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE). Exp. Neurol. 2010, 226, 15-23.
4. Alves, C.C.S.; Castro, S.B.R.; Costa, C.F.; Dias, A.T.; Alves, C.J.; Rodrigues, M.F.; Teixeira, H.C.; Almeida, M.V.; Ferreira, A.P. Anthraquinone derivative o,o'-bis-(3'-iodopropyl)-1,4-dihidroxyanthraquinone modulates immune response and improves experimental autoimmune encephalomyelitis. Int. Immunopharmacol. 2012, 14, 127-132.
5. Pöllinger, B. IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis. J. Mol. Med. 2012, 90, 613-624.
6. Guimarães-Santos, A.; Santos, D.S.; Santos, I.R.; Lima, R.R.; Pereira, A.; de Moura, L.S.; Carvalho, R.N., Jr.; Lameira, O.; Gomes-Leal, W. Copaiba oil-resin treatment is neuroprotective and reduces neutrophil recruitment and microglia activation after motor cortex excitotoxic injury. Evid.-Based Complement. Alternat. Med. 2012, 2012, doi:10.1155/2012/918174.
7. Da Silva Filho, A.A.; Bueno, P.C.P.; Gregório, L.E.; Silva, M.L.A.; Albuquerque, S.; Bastos, J.K. In vitro trypanocidal activity evaluation of crude extract and isolated compounds from Baccharis dracunculifolia D.C. (Asteraceae). J. Pharm. Pharmacol. 2004, 56, 1195-1199.
8. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311-335.
9. Veiga Junior, V.F.; Rosas, E.C.; Carvalho, M.V.; Henriques, M.G.M.O.; Pinto, A.C. Chemical composition and anti-inflammatory activity of copaiba oils from Copaifera cearensis huber ex Ducke, Copaifera reticulata Ducke and Copaifera multijuga Hayne - A comparative study. J. Ethnopharmacol. 2007, 112, 248-254.
10. Leandro, L.M.; Vargas, F.S.; Barbosa, P.C.S.; Neves, J.K.O.; Silva, J.A.; Veiga-Junior, V.F. Chemistry and biological activities of terpenoids from Copaiba (Copaifera spp.) oleoresins. Molecules 2012, 17, 3866-3889.
11. Veiga-Junior, V.F.; Zunino, L.; Calixto, J.B.; Patitucci, M.L.; Pinto, A.C. Phytochemical and antioedematogenic studies of commercial copaiba oils available in Brazil. Phytother. Res. 2001, 15, 476-480.
12. Adams, R.P. Identification of Essential Oils Components by Gas Chromatography/Mass Spectrometry; Allured Publishing Corporation: Carol Stream, IL, USA, 2005; p. 4.
13. Deus, R.J.A.; Carvalho, A.S.C.; Banna, D.A.D.S.; Arruda, M.S.P.; Alves, C.N.; Santos, A.S. In vitro fungitoxic effect of the oil-resin and the essential oil of copaíba (Copaifera multijuga Hayne). Rev. Bras. Plantas Med. 2009, 11, 347-353.
14. Barbosa, P.C.S.; Medeiros, R.S.; Sampaio, P.T.B.; Vieira, G.; Wiedemann, L.S.M.; Veiga-Júnior, V.F. Influence of abiotic factors on the chemical composition of copaíba oil (Copaifera multijuga Hayne): Soil composition, seasonality and diameter at breast height. J. Braz. Chem. Soc. 2012, 23, 1823-1833.
15. Trindade, F.T.T.; Stabeli, R.G.; Pereira, A.A.; Facundo, V.A.; Silva, A.A. Copaifera multijuga ethanolic extracts, oilresin and its derivatives display larvicidal activity against Anopheles darlingi and Aedes aegypti (Diptera: Culicidae). Rev. Bras. Farmacogn. 2013, 23, 464-470.
16. Chen, X.; Pi, R.; Zou, Y.; Liu, M.; Ma, X.; Jiang, Y.; Mao, X.; Hu, X. Attenuation of experimental autoimmune encephalomyelitis in C57 bl/6 mice by osthole, a natural coumarin. Eur. J. Pharmacol. 2010, 629, 40-46.
17. Dutra, R.C.; de Cezaro de Souza, P.R.; Bento, A.F.; Marcon, R.; Bicca, M.A.; Pianowski, L.F.; Calixto, J.B. Euphol prevents experimental autoimmune encephalomyelitis in mice: Evidence for the underlying mechanisms. Biochem. Pharmacol. 2012, 83, 531-542.
18. Gelmini, F.; Beretta, G.; Anselmi, C.; Centini, M.; Magni, P.; Ruscica, M.; Cavalchini, A.; Maffei Facino, R. GC-MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii desf. and a preliminary in vivo evaluation of its antipsoriatic effect. Int. J. Pharm. 2013, 440, 170-178.
19. Barfod, L.; Kemp, K.; Hansen, M.; kharazmi, A. Chalcones from Chinese liquorice inhibit proliferation of T cells and production of cytokines. Int. Immunopharmacol. 2002, 2, 545-555.
20. Furusawa, J.; Funakoshi-Tago, M.; Tago, K.; Mashino, T.; Inoue, H.; Sonoda, Y.; Kasahara, T. Licochalcone A significantly suppresses LPS signaling pathway through the inhibition of NF-κB p65 phosphorylation at serine 276. Cell. Signal. 2009, 21, 778-785.
21. Funakoshi-Tago, M.; Tago, K.; Nishizawa, C.; Takahashi, K.; Mashino, T.; Iwata, S.; Inoue, H.; Sonoda, Y.; Kasahara, T. Licochalcone A is a potent inhibitor of TEL-Jak2-mediated transformation through the specific inhibition of Stat3 activation. Biochem. Pharmacol. 2008, 76, 1681-1693.
22. Castro, S.B.R.; Junior, C.O.R.; Alves, C.C.S.; Dias, A.T.; Alves, L.L.; Mazzoccoli, L.; Mesquita, F.P.; Figueiredo, N.S.V.; Juliano, M.A.; Castañon, M.C.M.N.; et al. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment. Int. Immunopharmacol. 2012, 12, 465-470.
23. Linker, R.A.; Lee, D.H.; Ryan, S.; van Dam, A.M.; Conrad, R.; Bista, P.; Zeng, W.; Hronowsky, X.; Buko, A.; Chollate, S.; et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 2010, 34, 678-692.
24. Leiper J.; Nandi, M. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat. Rev. Drug Discov. 2011, 10, 277-291.
25. Lee, E.; Chanamara, S.; Pleasure, D.; Soulika, A.M. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. J. Neuroinflamm. 2012, 9, 7. doi:10.1186/1742-2094-9-7.
26. Rodgers J.M.; Miller S.D. Cytokine control of inflammation and repair in the pathology of multiple sclerosis. Yale J. Biol. Med. 2012, 85, 447-468.
27. Wang X.; Ma, C.; Wu, J.; Zhu, J. Roles of T helper 17 cells and Interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and guillainbarr e syndrome as well as their animal models. J. Neurosci. Res. 2013, 91, 871-881.
28. Fernandes, E.S.; Passos, G.F.; Medeiros, R.; da Cunha, F.M.; Ferreira, J.; Campos, M.M.; Pianowski, L.F.; Calixto, J.B. Anti-inflammatory effects of compounds alpha-humulene and (-)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea. Eur. J. Pharmacol. 2007, 569, 228-236.
29. Gertsch, J. Antiinflammatory cannabinoids in diet - Towards a better understanding of cb2 receptor action? Commun. Integr. Biol. 2008, 1, 26-28.
30. Pacher, P.; Mechoulam, R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog. Lipid Res. 2011, 50, 193-211.
31. Howlett, A.C.; Barth, F.; Bonner, T.I.; Cabral, G.; Casellas, P.; Devane, W.A.; Felder, C.C.; Herkenham, M.; Mackie, K.; Martin, B.R.; et al. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54, 161-202.
32. McLafferty, F.W. Wiley Registry of Mass Spectral Data, 8th ed.; Hoboken, N.J., Ed.; John Wiley & Sons: New York, NY, USA, 2008.
33. Pick, E.; Mizel, D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J. Immunol. Methods 1981, 46, 211-226.
34. Green, L.C.; Wagner, D.A.; Glogowski, J.; Skipper, P.L.; Wishnok, J.S.; Tannenbaum, S.R. Analysis of nitrate, nitrite, and [15n]nitrate in biological fluids. Anal. Biochem. 1982, 126, 131-138.